Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly to Focus on Cancer, Diabetes in China, CEO Says
Bloomberg
Tuesday, March 20, 2012 - 10:31am
tags:
Eli Lilly, cancer, diabetes, Pharma CEOs, China, John Lechleiter
AstraZeneca Won’t Seek Approval for Targacept Antidepressant
Bloomberg
Tuesday, March 20, 2012 - 10:18am
tags:
Targacept, antidepressants, AstraZeneca
Pfizer’s Rheumatoid Arthritis Pill: Not A Slam Dunk
Pharmalot
Tuesday, March 20, 2012 - 10:17am
tags:
Pfizer, rheumatoid arthritis, tofacitinib
Pozen's Final Results On Ulcer Safe Aspirin Can Send Shares Soaring
Seeking Alpha
Tuesday, March 20, 2012 - 10:15am
tags:
Pozen, asprin, ulcers, PA32540
Neurocrine Could Be A Major Biotech Comeback Story
Seeking Alpha
Tuesday, March 20, 2012 - 10:14am
tags:
Neurocrine, Abbott Laboratories, GSK
For Sale: Pfizer's Growth Prospects
Seeking Alpha
Tuesday, March 20, 2012 - 10:11am
tags:
Pfizer
An FDA Advisory Panel Doubleheader
Motley Fool
Tuesday, March 20, 2012 - 10:07am
tags:
FDA, advisory panels, Votrient, soft tissue sarcomas, GSK, Merck, ridaforolimus, Ariad Pharmaceuticals
FDA approves first low-cost versions of osteoporosis drug from 3 generic drugmakers
Yahoo/AP
Tuesday, March 20, 2012 - 10:04am
tags:
generics, FDA, osteoporosis, Boniva, Apotex, Orchid Healthcare, Mylan
Cardiome Investors: Why Shares Crashed 50%
Motley Fool
Tuesday, March 20, 2012 - 10:02am
tags:
Cardiome, Merck, Astellas, Vernakalant
Tanezumab: 2 Big Reasons for This Drug's Second Look
Motley Fool
Tuesday, March 20, 2012 - 10:00am
tags:
tanezumab, Pfizer, NGF blockers
Why Ampio's Big Rebound Run May Not Be Done
Seeking Alpha
Tuesday, March 20, 2012 - 9:58am
tags:
Ampio, Optina
Amylin Pharmaceuticals Pulling Ahead Of Roche In Anti-Obesity Drugs?
Seeking Alpha
Monday, March 19, 2012 - 10:47am
tags:
Roche, obesity, Amylin, diabetes, Xenical, Orlistat, metreleptin, Alli
The Unappreciated Awesomeness at Sequenom
Motley Fool
Monday, March 19, 2012 - 10:45am
tags:
Sequenom
Abbott Sues Watson Over Patents for Cholesterol Drug Niaspan
Bloomberg
Monday, March 19, 2012 - 10:44am
tags:
Watson, generics, patents, Niaspan, Abbott Laboratories
QLT Inc. receives Orphan Drug Designation for Visudyne
The Fly on the Wall
Monday, March 19, 2012 - 10:24am
tags:
orphan drugs, Visudyne, QLT, central serous chorioretinopathy
A Review Of My Last 3 Small Cap Bio-Pharma Picks
Seeking Alpha
Monday, March 19, 2012 - 10:22am
tags:
Ariad Pharmaceuticals, Acadia, Antares, BioSante, NuPathe, Dendreon
Friday's Close Has Amarin Investors Smelling News
Seeking Alpha
Monday, March 19, 2012 - 10:21am
tags:
Amarin
Elan's Alzheimer's-Fueled Run Means Investors Are Forgetting the Past
TheStreet.com
Monday, March 19, 2012 - 10:20am
tags:
Elan, Alzheimer's disease, bapineuzumab
Glaxo Strikes Deal With Indian Firm To Track Social Media
Reuters, India
Monday, March 19, 2012 - 9:24am
tags:
India, GSK, social media, Infosys
Cardiome provides update on Merck's development plans for Vernakalant Oral
The Fly on the Wall
Monday, March 19, 2012 - 9:22am
tags:
Cardiome, Merck, Vernakalant, atrial fibrillation

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.